Combining this investigation and previous research studies, we could preliminarily conclude that ABCC1, ABCC4, and ABCC5 reduce drug sensitivity by influencing drug transport out of cells, thus resulting in a poor prognosis in these patients with HCC. Here, ABCC1 is linked to hepatocellular carcinoma.